Results found: 3

Number of results on page

Search results

Search:
in the keywords: vitrectomy

Sort By:

Limit search:

Vitrectomy in stage 5 retinopathy of prematurity - surgical and functional results of 1000 vitrectomies

100%

Prost M. E.

OphthaTherapy

2021

vol. 8

issue 2

108-113

Despite improvements in neonatal care, retinopathy of prematurity is still leading cause of blindness in the world. The most treatment problems pose stage 4 and 5 of this disease. Performing vitrectomy in stage 5 is a subject of controversy among ophthalmologists due to unsatisfactory functional results after the surgery. Therefore, our aim was to present the results of 1000 vitrectomies performed by the author in years 1994–2019 in 1018 eyes of 692 children with stage 5 retinopathy of prematurity. In these children lens sparing vitrectomies and lensectomy-vitrectomy with limbal approach were performed. The results were compared with visual function of 127 untreated children with stage 5 retinopathy of prematurity. Visual acuity of treated patients ranged from 0.05 to no light perception in stage 5 and from no light perception to finger counting in the untreated group. Comparing the functional results of treated and untreated patients, it can be concluded that vitrectomy gives a better chance of gaining useful vision.

Shall intraoperative OCT become standard equipment of modern operating room?

100%

Kaczmarek D. M., Kaczmarek R.

OphthaTherapy

2023

vol. 10

issue 3

173-177

The role of intraoperative OCT (iOCT) in ophthalmic surgery is still a matter of active research and enhancements to integrative technologies. Further research is necessary to better define the specific applications of iOCT that impact surgical decision-making and as such help to achieve better patient outcomes, both in anterior and in posterior segment of the eye. In time to come advancements in integrative systems, OCT-friendly instrumentation, and software algorithms will most likely expand the horizon of iOCT even further.

Macular hemorrhage - therapy

72%

Gawlak M., Guzek K., Kuźlik B., Pandey A., Prokop D., Cwalina O., Czarnacka K., Chmura-Hołyst A., Alsoubie I., Sajak-Hydzik K., Pawlicka I., Piskorz A., Kozak M., Roszkowska A.

OphthaTherapy

2023

vol. 10

issue 1

57-62

Krwotok podsiatkówkowy do plamki żółtej i jego leczenie pozostają poważnym zagadnieniem okulistycznym. Obecnie brakuje dokładnych algorytmów, które można byłoby stosować w praktyce klinicznej. Użyteczność każdej z metod leczenia jest zależna od indywidualnych czynników współistniejących. Preparaty anty-VEGF wydają się w związku z tym kluczowe w leczeniu pacjentów ze zmianami o charakterze waskulopatii, natomiast w leczeniu pourazowego krwotoku do plamki ustępują one miejsca pneumatycznemu przesunięciu. Operacje, mimo większej inwazyjności i ryzyka, pozostają niezastąpione w przypadku dużych wylewów, znacznie przyspieszając ewakuację skrzepu. Celem poniższej pracy jest zbiorcze przedstawienie aktualnych badań dotyczących tego zagadnienia, a dzięki temu usystematyzowanie użyteczności danej metody ze względu chociażby na pierwotną przyczynę wystąpienia krwotoku. W niniejszym zestawieniu znalazły się obecnie stosowane w praktyce klinicznej metody, tj.: pneumatyczne przesunięcie krwi, terapia anty-VEGF, rtPA oraz metody operacyjne.

Submacular hemorrhage treatment is still an important issue in ophthalmology. At present we lack algorithms of treatment that could be used in clinical practice. Efficacy of every treatment method seems to differ by individual factors simultaneously existing in each patient. Therefore, anti-VEGF agents remain crucial in treating patients with coexisting vasculopathy, while in posttraumatic hemorrhage we should lean towards other approaches, like pneumatic displacement. Operative methods, despite being more invasive and burdened with higher potential risk, are indispensable in large hemorrhages, significantly speeding up clot removal. The primary aim of this work is to collect recent data regarding this issue and to determine usefulness of treatment methods in specific cases, regarding factors such as hemorrhage pathophysiology. The following article pertains to currently used treatment methods, such as: pneumatic displacement, anti-VEGF therapy, rtPA and operative methods.

Refine search results

3 OphthaTherapy

2 2023

1 2021

1 Alsoubie I.

1 Chmura-Hołyst A.

1 Cwalina O.

1 Czarnacka K.

1 Gawlak M.

1 Guzek K.

1 Kaczmarek D. M.

1 Kaczmarek R.

1 Kozak M.

1 Kuźlik B.

1 Pandey A.

1 Pawlicka I.

1 Piskorz A.

1 Prokop D.

1 Prost M. E.

1 Roszkowska A.

1 Sajak-Hydzik K.

Search results

Vitrectomy in stage 5 retinopathy of prematurity - surgical and functional results of 1000 vitrectomies

Shall intraoperative OCT become standard equipment of modern operating room?

Macular hemorrhage - therapy